News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 07, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Growing Concern over the Efficacy of Vancomycin is Prompting Greater Use of Branded Therapies for the Treatment of MRSA Infections

 Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant...

Jul 07, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Novo Nordisk's Insulin Degludec/Liraglutide is Set to Become the Clinical Gold-Standard Among Fixed-Dose Combination Therapies for Type 2 Diabetes

 Decision Resources Group finds that Novo Nordisk's fixed-dose combination (FDC) therapy insulin degludec/liraglutide (Xultophy, formerly known...

Jul 02, 2014, 13:45 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Medicaid Expansion "Dominoes" Continue To Fall As More States Enact And Submit Waivers

 Decision Resources Group expects most states to move toward Medicaid expansion in the next few years. Two key factors continue to drive the...

Jul 02, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Despite an Initial Decline in the European Market, the North American and European Dental Implant Markets Will Grow to Reach a Combined Value of $4.2 Billion by 2022

 Decision Resources Group finds that the North American and European markets for dental implants will expand through 2022 to reach a combined...

Jul 02, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Affordable Care Act Driving Significant Change in Indianapolis Market, Including the Dissolution of the Indiana Accountable Care Consortium

 Decision Resources Group finds that the Indianapolis market is in significant flux as it implements several key initiatives of the Affordable...

Jul 01, 2014, 14:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

In China, Surveyed Nephrologists Report Significant Declines in the Use of ESAs in Stage 3, 4 and 5 Chronic Kidney Disease Non-Dialysis Patient Populations, Compared with 2011

 Decision Resources Group finds that patient chart data submitted by surveyed nephrologists in China reveals that, consistent with 2011, the...

Jul 01, 2014, 10:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Chinese Facial Injectable Market Will Grow Nearly 20 Percent Annually Through 2022

 Decision Resources Group finds that the Chinese market for facial injectables, including hyaluronic acid (HA) dermal fillers and botulinum...

Jun 30, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022

 Decision Resources Group finds that the immunotherapy market will experience considerable growth through 2022, increasing from $1.1 billion in...

Jun 26, 2014, 11:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

EU5 Payers are Looking for Superior Clinical Efficacy for COPD, in Light of the Launch of Novartis's Ultibro, the First LABA/LAMA Fixed-Dose Combination in Europe

 Decision Resources Group finds that surveyed pulmonologists in the EU5 (France, Germany, Italy, Spain and the United Kingdom) estimate that...

Jun 24, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Global Dental CAD/CAM System Market Will See Strong Growth to Reach a Value of Over $760 Million in 2022

Decision Resources Group finds that high cost and low awareness of dental computer-aided design/computer-aided manufacturing (CAD/CAM) systems have...

Jun 23, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Psychiatrists Would Prescribe Otsuka/Lundbeck's Brexpiprazole to 12 Percent of Their Treatment-Resistant Depression Patients

 Decision Resources Group finds that surveyed U.S. psychiatrists are receptive to novel adjunctive therapies to antidepressants for...

Jun 19, 2014, 13:36 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Nearly Three-Quarters of Surveyed Primary Care Physicians are Unfamiliar with Approved Direct Acting Antivirals for Hepatitis C Virus

 Decision Resources Group finds that less than one-third of surveyed primary care physicians (PCPs) are familiar with the first-generation...

Jun 19, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments

Decision Resources Group (DRG) finds that, according to surveyed U.S. and European oncologists, improvement in efficacy endpoints are the most...

Jun 18, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

U.S. Electrophysiology Mapping and Ablation Device Market Will Grow at a 10 Percent Compound Annual Growth Rate through 2022

Decision Resources Group finds that the U.S. electrophysiology (EP) mapping and ablation device market will continue to experience strong growth...

Jun 18, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Availability of New Therapies for Hepatitis C Virus Will Increase the Drug-Treated Population in China

Decision Resources Group finds that China's market for hepatitis C virus (HCV) drugs will be driven by an increase in its drug-treated population,...

Jun 17, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Colombia is an Attractive Emerging Pharmaceutical Market That is Expected to Grow at a Compound Annual Rate of 7.3 Percent Between 2013 and 2016

 Decision Resources Group finds that Colombia has an attractive pharmaceutical market that should appeal to multinational companies looking for...

Jun 16, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Governments Face Immense Pressure to Develop Financially Sustainable Healthcare Systems in the Asia-Pacific Region

Decision Resources Group finds that, despite the positive outlook and relatively strong growth potential for pharmaceutical companies in the...

Jun 12, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Pharma Challenged by Increasing Global Market Access Complexity as 2015 Planning Intensifies

Decision Resources Group finds that global market access planning is growing in complexity as each country's evolving regulations change the...

Jun 12, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis

 Decision Resources Group finds that, within one year of commercial availability, 100 percent of surveyed U.S. neurologists have prescribed...

Jun 12, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Anticipated Approval of Three New Therapies Through 2023 Will Expand Treatment Options for the Control and Relief of Motor Symptoms in Huntington's Disease

 Decision Resources Group finds that three therapies, Teva's Huntexil, Auspex's SD-809 and Raptor's Procysbi, will likely receive regulatory...